512 related articles for article (PubMed ID: 24512387)
21. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
[TBL] [Abstract][Full Text] [Related]
22. Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.
Privat N; Levavasseur E; Yildirim S; Hannaoui S; Brandel JP; Laplanche JL; Béringue V; Seilhean D; Haïk S
J Biol Chem; 2017 Oct; 292(40):16688-16696. PubMed ID: 28821618
[TBL] [Abstract][Full Text] [Related]
23. The propagation of prion-like protein inclusions in neurodegenerative diseases.
Goedert M; Clavaguera F; Tolnay M
Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical role of prion protein aggregates in redox-iron induced toxicity.
Das D; Luo X; Singh A; Gu Y; Ghosh S; Mukhopadhyay CK; Chen SG; Sy MS; Kong Q; Singh N
PLoS One; 2010 Jul; 5(7):e11420. PubMed ID: 20625431
[TBL] [Abstract][Full Text] [Related]
25. Prion disease: a tale of folds and strains.
Kretzschmar H; Tatzelt J
Brain Pathol; 2013 May; 23(3):321-32. PubMed ID: 23587138
[TBL] [Abstract][Full Text] [Related]
26. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.
Singh A; Mohan ML; Isaac AO; Luo X; Petrak J; Vyoral D; Singh N
PLoS One; 2009; 4(2):e4468. PubMed ID: 19212444
[TBL] [Abstract][Full Text] [Related]
27. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
Vargas JY; Grudina C; Zurzolo C
Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
[TBL] [Abstract][Full Text] [Related]
28. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 Prions.
Nonaka T; Hasegawa M
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28108532
[TBL] [Abstract][Full Text] [Related]
30. The prion-ZIP connection: From cousins to partners in iron uptake.
Singh N; Asthana A; Baksi S; Desai V; Haldar S; Hari S; Tripathi AK
Prion; 2015; 9(6):420-8. PubMed ID: 26689487
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer's Disease (AD) and Prion Disease (PrD).
Lukiw WJ
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204666
[TBL] [Abstract][Full Text] [Related]
32. How strong is the evidence that Parkinson's disease is a prion disorder?
Brundin P; Ma J; Kordower JH
Curr Opin Neurol; 2016 Aug; 29(4):459-66. PubMed ID: 27257944
[TBL] [Abstract][Full Text] [Related]
33. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
Nonaka T
Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
[TBL] [Abstract][Full Text] [Related]
34. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
35. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
Moreno-Gonzalez I; Soto C
Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
[TBL] [Abstract][Full Text] [Related]
36. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
Jaunmuktane Z; Brandner S
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
[TBL] [Abstract][Full Text] [Related]
37. Prying into the Prion Hypothesis for Parkinson's Disease.
Brundin P; Melki R
J Neurosci; 2017 Oct; 37(41):9808-9818. PubMed ID: 29021298
[TBL] [Abstract][Full Text] [Related]
38. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
Wagner J; Ryazanov S; Leonov A; Levin J; Shi S; Schmidt F; Prix C; Pan-Montojo F; Bertsch U; Mitteregger-Kretzschmar G; Geissen M; Eiden M; Leidel F; Hirschberger T; Deeg AA; Krauth JJ; Zinth W; Tavan P; Pilger J; Zweckstetter M; Frank T; Bähr M; Weishaupt JH; Uhr M; Urlaub H; Teichmann U; Samwer M; Bötzel K; Groschup M; Kretzschmar H; Griesinger C; Giese A
Acta Neuropathol; 2013 Jun; 125(6):795-813. PubMed ID: 23604588
[TBL] [Abstract][Full Text] [Related]
39. Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.
Tyson T; Steiner JA; Brundin P
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):275-289. PubMed ID: 26617280
[TBL] [Abstract][Full Text] [Related]
40. Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.
Singh N; Haldar S; Tripathi AK; Horback K; Wong J; Sharma D; Beserra A; Suda S; Anbalagan C; Dev S; Mukhopadhyay CK; Singh A
Antioxid Redox Signal; 2014 Mar; 20(8):1324-63. PubMed ID: 23815406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
